Published in Proc Soc Exp Biol Med on November 01, 1978
Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther (1968) 1.34
Effects of several saluretic-diuretic agents on renal hemodynamics. J Pharmacol Exp Ther (1966) 1.27
Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest (1971) 1.15
Specificity of the inhibitory effect of "uremic" serum on p-aminohippurate transport. Proc Soc Exp Biol Med (1968) 1.14
Influence of probenecid and alterations in acid-base balance of the saluretic activity of furosemide. J Pharmacol Exp Ther (1965) 1.13
Lack of correlation between natriuretic activity and inhibition of renal Nak-activated ATPase. Proc Soc Exp Biol Med (1965) 1.13
Renin release: relation to renal sodium load and dissociation from hemodynamic changes. Circ Res (1968) 1.07
Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J Pharmacol Exp Ther (1976) 1.06
Age-related nephropathy in laboratory rats. FASEB J (1988) 1.01
Effects of asphyxia on cardiac output and organ blood flow in the newborn piglet. Pediatr Res (1978) 0.95
Perinatal renal pharmacology. Annu Rev Pharmacol Toxicol (1979) 0.94
Mechanism of natriuretic action of bradykinin. Am J Physiol (1969) 0.93
Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors. Circ Res (1975) 0.91
Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol Behav (1989) 0.90
Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys. Toxicology (1987) 0.90
Concomitant dietary exposure to polychlorinated biphenyls and polybrominated biphenyls: tissue distribution and arylhydrocarbon hydroxylase activity in lactating rats. Toxicol Appl Pharmacol (1979) 0.90
Enzymes of renal origin in urine as indicators of nephrotoxicity. Toxicol Appl Pharmacol (1977) 0.90
Renin secretion by rat kidney slices in vitro. Proc Soc Exp Biol Med (1974) 0.89
Effects of environmental chemicals on kidney metabolism and function. Kidney Int (1980) 0.88
Age-related differences in susceptibility to renal ischemia in rats. Toxicol Appl Pharmacol (1987) 0.88
Effect of monocrotaline ingestion on liver, kidney, and lung of rats. Toxicol Appl Pharmacol (1981) 0.87
Development of angiotensin-converting enzyme in fetal rat lungs. Am J Physiol (1979) 0.87
Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. J Pediatr (1984) 0.87
Role of the renin-angiotensin system in hypertension after coarctation of the aorta. J Lab Clin Med (1984) 0.86
Transluminal arterial dilation of a postsurgical stenosis of renal artery implant in a child with recurrent hypertension. Pediatrics (1982) 0.86
Carcinogenicity study of auranofin, an orally administered gold compound, in mice. Fundam Appl Toxicol (1988) 0.85
Angiotensin-converting enzyme in developing lung and kidney. Am J Physiol (1978) 0.85
The effect of vasodilator drugs on the noradrenaline constrictor response in the isolated mesenteric artery. Can J Physiol Pharmacol (1969) 0.85
A positive correlation between natriuresis and inhibition of renal Na-K adenosine triphosphatase by ouabain. Proc Soc Exp Biol Med (1969) 0.85
cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment. Toxicol Appl Pharmacol (1981) 0.85
Nephrotoxicity of hexachloro-1,3-butadiene in the mouse: the effect of age, sex, strain, monooxygenase modifiers, and the role of glutathione. Toxicol Appl Pharmacol (1984) 0.84
Mechanism of renal handling of angiotensin II in the dog. Circ Res (1973) 0.84
Intrarenal secretion of renin in the dog: effect of furosemide. Am J Physiol (1973) 0.84
Depletion by 1,2-dibromoethane, 1,2-dibromo-3-chloropropane, tris(2,3-dibromopropyl)phosphate, and hexachloro-1,3-butadiene of reduced non-protein sulfhydryl groups in target and non-target organs. Biochem Pharmacol (1981) 0.84
Nephrotoxicity of paraquat in mice. Toxicol Appl Pharmacol (1975) 0.83
Effects of aminoglycosides on glomerular permeability, tubular reabsorption, and intracellular catabolism of the cationic low-molecular-weight protein lysozyme. Toxicol Appl Pharmacol (1983) 0.83
In vitro metabolism of C-14-labeled amino acids by sheep kidney cortex and medulla. Am J Physiol (1966) 0.83
Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats. Res Commun Chem Pathol Pharmacol (1972) 0.83
Effect of furosemide on renal hilar lymph flow. Arch Int Pharmacodyn Ther (1976) 0.82
Release of vasoactive materials from the kidney by diuretics. J Clin Pharmacol (1977) 0.82
Renal ultrastructural and biochemical injuries induced by aminoglycosides. Environ Health Perspect (1984) 0.82
Postnatal development of the renin-angiotensin system in rats. Am J Physiol (1980) 0.82
Nephrotoxicity of Hexachloro-1:3-butadiene in the rat: the effect of age, sex, and strain. Toxicol Appl Pharmacol (1983) 0.82
Effect of 2,3,7,8-tetrachlorodibenzo-rho-dioxin on renal function in the rat. J Toxicol Environ Health (1976) 0.81
Effects of gentamicin on renal function in isolated perfused kidneys from male and female rats. Toxicol Lett (1985) 0.81
Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney. J Pharmacol Exp Ther (1986) 0.80
Role of hemodynamic changes in the effect of furosemide on the renal concentrating mechanism. Eur J Pharmacol (1970) 0.80
Mechanism of chloroform nephrotoxicity. II. In vitro evidence for renal metabolism of chloroform in mice. Toxicol Appl Pharmacol (1983) 0.80
Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration. Mol Pharmacol (1983) 0.80
Analysis of gentamicin uptake by rat renal cortical slices. Toxicol Appl Pharmacol (1978) 0.80
Nephrotoxicity of chloroform: metabolism to phosgene by the mouse kidney. Toxicol Appl Pharmacol (1984) 0.80
Acetaminophen nephrotoxicity in the rat. II. Strain differences in nephrotoxicity and metabolism of p-aminophenol, a metabolite of acetaminophen. Toxicol Appl Pharmacol (1983) 0.80
Urinary excretion of renin in the dog: effect of changes in plasma renin. J Pharmacol Exp Ther (1983) 0.80
Potentiation of hepatic and renal toxicity of various compounds by prior exposure to polybrominated biphenyls. Environ Health Perspect (1978) 0.80
Developmental aspects of renal pharmacology. Pharmacol Ther (1982) 0.80
Mechanism of prostaglandin E(2) stimulation of renin secretion. Proc Soc Exp Biol Med (1978) 0.80
Effects of age and sex on hexachloro-1,3-butadiene toxicity in the Fischer 344 rat. Life Sci (1983) 0.80
Effects of polybrominated biphenyls on kidney function and activity of renal microsomal enzymes. Environ Health Perspect (1978) 0.80
Nephrotoxicity and hepatotoxicity of chloroform in mice: effect of deuterium substitution. J Toxicol Environ Health (1982) 0.79
Effect of tolmetin on renal function and prostaglandin metabolism. J Pharmacol Exp Ther (1978) 0.79
Maturation of renal organic acid transport: substrate stimulation by penicillin. Science (1969) 0.79
The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function. Toxicol Appl Pharmacol (1983) 0.79
Role of alterations in renal hemodynamics in the natriuretic action of glucagon. Arch Int Pharmacodyn Ther (1970) 0.79
Hepatic and renal conjugation (Phase II) enzyme activities in young adult, middle-aged, and senescent male Sprague-Dawley rats. Proc Soc Exp Biol Med (1991) 0.79
Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol Appl Pharmacol (1983) 0.79
Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice. Toxicol Appl Pharmacol (1984) 0.79
Functional maturation of renal PAH transport in the dog. Can J Physiol Pharmacol (1970) 0.79
Effects of polybrominated biphenyls on metabolism of testosterone by rat hepatic microsomes. Toxicol Appl Pharmacol (1982) 0.79
Glutathione S-transferases: an evaluation of their role in renal organic anion transport. J Pharmacol Exp Ther (1977) 0.79
Acetaminophen nephrotoxicity in the rat. I. Strain differences in nephrotoxicity and metabolism. Toxicol Appl Pharmacol (1983) 0.79
Gentamicin-induced renal metabolic alterations in newborn rat kidney: lack of potentiation by vancomycin. Toxicol Appl Pharmacol (1989) 0.79
Effect of inhibition of peptidase activity on distribution of intrarenal blood flow. Am J Physiol (1975) 0.79
Paraquat concentration and renal function in mice fed purified and cereal-based diets. Drug Nutr Interact (1983) 0.79
Metabolic activation of nephrotoxic haloalkanes. Fed Proc (1980) 0.79
Action of exogenously administered steroid hormones following perinatal exposure to polybrominated biphenyls. J Toxicol Environ Health (1979) 0.79
Effects of indomethacin on furosemide-induced changes in renal blood flow. Proc Soc Exp Biol Med (1975) 0.79
Postnatal development of renal and hepatic drug-metabolizing enzymes in male and female Fischer 344 rats. Life Sci (1981) 0.79
Nephrotoxicity of p-aminophenol, a metabolite of acetaminophen, in the fischer 344 rat. Toxicol Appl Pharmacol (1982) 0.79
The renal handling of 2,4,5-trichlorophenoxy- acetic acid (2,4,5-T) in the dog. Food Cosmet Toxicol (1976) 0.78
Glucose intolerance following cis-platinum treatment in rats. Toxicology (1982) 0.78
Renal protein degradation: a biochemical target of specific nephrotoxicants. Fundam Appl Toxicol (1983) 0.78
Effects of asphyxia on renal function in the newborn piglet. Pediatr Res (1978) 0.78
Fluoride and methoxyflurane nephropathy. Anesthesiology (1971) 0.78
Effect of anesthesia on cardiovascular and renal function in the newborn piglet. J Pharmacol Exp Ther (1979) 0.78